RACHEL KLOOSTERMAN: Open Payments
NPI 1194178129 · GREENVILLE, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$847 in 27 payments from 11 companies in 2025. Trend: 2023 $224 · 2024 $657 · 2025 $847
Food & beverage: $847
| Company | Payments | Amount |
|---|---|---|
| UCB, Inc. | 9 | $330 |
| AstraZeneca Pharmaceuticals LP | 6 | $193 |
| E.R. Squibb & Sons, L.L.C. | 2 | $74 |
| Fresenius Kabi USA, LLC | 2 | $55 |
| ABBVIE INC. | 2 | $54 |
| Bioventus LLC | 1 | $34 |
| GENZYME CORPORATION | 1 | $31 |
| Amgen Inc. | 1 | $24 |
| PFIZER INC. | 1 | $20 |
| ANI Pharmaceuticals, Inc. | 1 | $18 |
Products named: Bimzelx, SAPHNELO, ORENCIA, RINVOQ, XCELL, KEVZARA, KRYSTEXXA, XELJANZ.
Industry payments across MI — which companies pay providers there.
